tiprankstipranks
Crispr Therapeutics AG (GB:0VRQ)
LSE:0VRQ

Crispr Therapeutics AG Blogger Opinions & Sentiment

0 Followers

Blogger Sentiment

Bullish: 94.00%
Sector Average
Bullish
GB:0VRQ Blogger sentiment is based on 17 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
41% SeekingAlpha
29% InvestorPlace
17% TipRanks Contributor
13% Others
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

CRISPR Therapeutics: Promising Pipeline, Fickle Fundamentals
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Crispr Therapeutics: Innovation Day Showcases Upside Opportunities In Short And Long Term
SeekingAlpha
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Name
Blogger Rank
Blog
Date
Blogger Sentiment​
Follow
Article
Upgrade Banner
Zacks Equity Research
Bullish
CRISPR Therapeutics' (CRSP) Pipeline Development Fuels Growth
TipRanks Contributor
Bullish
CRISPR Therapeutics: Why Its Growth Potential Could Get Cheaper
Seeking Alpha
Bullish
Crispr Therapeutics' Continued Progress Warrants A Buy
Forbes
Bullish
Crispr Therapeutics: Innovation Day Showcases Upside Opportunities In Short And Long Term
InvestorPlace
Bullish
7 No-Brainer Biotech Stocks to Add to Your Buy List
TipRanks Contributor
Bullish
3 Cathie Wood Stocks to Count on in Q2
Seeking Alpha
Bullish
The Commercial Potential Of Crispr In Light Of Patent Challenges
Seeking Alpha
Bullish
Crispr Therapeutics: Tons Of Upside From Current Prices
Seeking Alpha
Bullish
Crispr Therapeutics' Giant Leap For Humankind
TipRanks Contributor
Bullish
CRSP: Investors Pumped by Unique Price Point, Intriguing Pipeline
Stocks with the Highest Top Blogger Ratings in the Healthcare sector
PSTTFPrescient Therapeutics Limited
PRRUFImmutep Ltd
IVIXFInvion Ltd.
CLVLFClinuvel Pharmaceuticals Limited
ATGGFActinogen Medical Limited

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis